Back to Research Hub
Bio-Techne Corporation
TECH
$54.41+1.76 (+3.34%)
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics.
StreetsValue research for Bio-Techne Corporation (TECH)
Members get the full report for Bio-Techne Corporation: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.